These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22343334)

  • 61. Impact of basiliximab on the proportion of regulatory T cells and their subsets early after renal transplantation: a preliminary report.
    Zhao T; Yang C; Xue Y; Qiu YY; Hu L; Qiu Y; Wang X; Yang B; Rong R; Xu M; Zhu T
    Transplant Proc; 2012 Jan; 44(1):175-8. PubMed ID: 22310608
    [TBL] [Abstract][Full Text] [Related]  

  • 62. ASP0028 in combination with suboptimal-dose of tacrolimus in Cynomolgus monkey renal transplantation model.
    Dun H; Song L; Ma A; Hu Y; Zeng L; Bai J; Zhang G; Zhang L; Koide K; Okada Y; Hanaoka K; Yamamoto R; Hirose J; Morokata T; Daloze P; Chen H
    Transpl Immunol; 2017 Feb; 40():57-65. PubMed ID: 28077266
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The major CD8 T cell effector memory subset in the normal and Chlamydia trachomatis-infected human endocervix is low in perforin.
    Ibana JA; Myers L; Porretta C; Lewis M; Taylor SN; Martin DH; Quayle AJ
    BMC Immunol; 2012 Dec; 13():66. PubMed ID: 23216954
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alemtuzumab with corticosteroid minimization for pediatric deceased donor renal transplantation: a seven-yr experience.
    Supe-Markovina K; Melquist JJ; Connolly D; DiCarlo HN; Waltzer WC; Fine RN; Darras FS
    Pediatr Transplant; 2014 Jun; 18(4):363-8. PubMed ID: 24712738
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunosuppressive drugs affect induction of IFNy+ Treg in vitro.
    Daniel V; Trojan K; Opelz G
    Hum Immunol; 2016 Jan; 77(1):146-152. PubMed ID: 26585777
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion.
    Pearl JP; Parris J; Hale DA; Hoffmann SC; Bernstein WB; McCoy KL; Swanson SJ; Mannon RB; Roederer M; Kirk AD
    Am J Transplant; 2005 Mar; 5(3):465-74. PubMed ID: 15707400
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients.
    Vallotton L; Hadaya K; Venetz JP; Buehler LH; Ciuffreda D; Nseir G; Codarri L; Villard J; Pantaleo G; Pascual M
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):2025-33. PubMed ID: 21757642
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy.
    Takahashi H; Sakakura K; Mito I; Ida S; Chikamatsu K
    Cancer Sci; 2016 Aug; 107(8):1065-71. PubMed ID: 27228557
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of late immunologic parameters among renal transplant recipients induced with Campath-1H.
    Alba A; Morales J; Fierro A; Zehnder C; Cao C; Orozco R; Herzog C; Calabrán L; Contreras L; Buckel E
    Transplant Proc; 2010; 42(1):253-6. PubMed ID: 20172322
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients.
    Uemoto S; Ozawa K; Kaido T; Mori A; Fujimoto Y
    Clin Exp Immunol; 2016 Apr; 184(1):126-36. PubMed ID: 26560892
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors.
    Meloni F; Morosini M; Solari N; Bini F; Vitulo P; Arbustini E; Pellegrini C; Fietta AM
    Int Immunopharmacol; 2006 Dec; 6(13-14):2002-10. PubMed ID: 17161354
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression.
    Ciancio G; Miller A; Burke GW; Gharagozloo H; Rosen A; Roth D; Kupin W; Pinna A; Cespedes M; Esquenazi V; Miller J
    Transplant Proc; 2001; 33(1-2):1013-4. PubMed ID: 11267169
    [No Abstract]   [Full Text] [Related]  

  • 74. Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis.
    Zhang X; Tao Y; Chopra M; Ahn M; Marcus KL; Choudhary N; Zhu H; Markovic-Plese S
    J Immunol; 2013 Dec; 191(12):5867-74. PubMed ID: 24198283
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience.
    Tan HP; Kaczorowski DJ; Basu A; Khan A; McCauley J; Marcos A; Fung JJ; Starzl TE; Shapiro R
    Transplantation; 2004 Dec; 78(11):1683-8. PubMed ID: 15591960
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alemtuzumab induction in kidney transplantation.
    Huang E; Cho YW; Shah T; Peng A; Hayashi R; Bunnapradist S
    Clin Transpl; 2005; ():343-54. PubMed ID: 17424750
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation.
    Betjes MGH; Litjens NHR
    PLoS One; 2020; 15(2):e0228096. PubMed ID: 32023273
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Early coupled up-regulation of interleukin-12 receptor beta-1 in CD8+ central memory and effector T cells for better clinical outcomes in liver transplant recipients.
    Uemoto S; Ozawa K; Kaido T; Mori A; Fujimoto Y; Ogawa K
    Clin Exp Immunol; 2015 Aug; 181(2):373-84. PubMed ID: 25603847
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Th17 cells in alemtuzumab-treated patients: the effect of long-term maintenance immunosuppressive therapy.
    Hester J; Mills N; Shankar S; Carvalho-Gaspar M; Friend P; Wood KJ
    Transplantation; 2011 Apr; 91(7):744-50. PubMed ID: 21412187
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Circulating lymphocyte subsets in different clinical situations after renal transplantation.
    van de Berg PJ; Hoevenaars EC; Yong SL; van Donselaar-van der Pant KA; van Tellingen A; Florquin S; van Lier RA; Bemelman FJ; ten Berge IJ
    Immunology; 2012 Jun; 136(2):198-207. PubMed ID: 22321054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.